236 related articles for article (PubMed ID: 31981364)
21. Stage-specific direct health care costs in patients with cutaneous malignant melanoma.
Lyth J; Carstensen J; Synnerstad I; Lindholm C
J Eur Acad Dermatol Venereol; 2016 May; 30(5):789-93. PubMed ID: 25807966
[TBL] [Abstract][Full Text] [Related]
22. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
23. Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register.
Lyth J; Mikiver R; Nielsen K; Isaksson K; Ingvar C
Eur J Cancer; 2016 May; 59():171-178. PubMed ID: 27046697
[TBL] [Abstract][Full Text] [Related]
24. The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.
Al-Dabagh A; Davis SA; Kinney MA; Huang K; Feldman SR
Am J Clin Dermatol; 2013 Jun; 14(3):155-61. PubMed ID: 23575550
[TBL] [Abstract][Full Text] [Related]
25. Real world prescription trends of methotrexate for psoriasis in Argentina: results of a national survey.
Mazzuoccolo LD; Luna PC; Marciano S; Castro Perez GA; Marchesi C; Nocito MJ; Martin Koller V; Lorenzo J; Koch C; Echeverria CM
J Dermatolog Treat; 2017 Nov; 28(7):631-634. PubMed ID: 28489482
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous malignant melanoma in women and the role of oral contraceptives.
Gefeller O; Hassan K; Wille L
Br J Dermatol; 1998 Jan; 138(1):122-4. PubMed ID: 9536234
[TBL] [Abstract][Full Text] [Related]
27. Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.
Nielsen K; Ingvar C; Måsbäck A; Westerdahl J; Borg A; Sandberg T; Jonsson N; Nagel J; Olsson H
Br J Dermatol; 2004 Mar; 150(3):531-6. PubMed ID: 15030338
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy.
Stern RS; Zierler S; Parrish JA
Cancer; 1982 Sep; 50(5):869-72. PubMed ID: 7093925
[TBL] [Abstract][Full Text] [Related]
29. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population.
Ródenas JM; Delgado-Rodríguez M; Herranz MT; Tercedor J; Serrano S
Cancer Causes Control; 1996 Mar; 7(2):275-83. PubMed ID: 8740740
[TBL] [Abstract][Full Text] [Related]
30. Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort.
Shimizu Y; Nakajima A; Inoue E; Shidara K; Sugimoto N; Seto Y; Tanaka E; Momohara S; Taniguchi A; Yamanaka H
Clin Rheumatol; 2017 Jun; 36(6):1237-1245. PubMed ID: 28455827
[TBL] [Abstract][Full Text] [Related]
31. PUVA and cancer risk: the Swedish follow-up study.
Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Ljunggren B; Andersson T; Molin L; Nylander-Lundqvist E; Emtestam L
Br J Dermatol; 1999 Jul; 141(1):108-12. PubMed ID: 10417523
[TBL] [Abstract][Full Text] [Related]
32. Prognostic risk factors of first recurrence in patients with primary stages I-II cutaneous malignant melanoma - from the population-based Swedish melanoma register.
Lyth J; Falk M; Maroti M; Eriksson H; Ingvar C
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1468-1474. PubMed ID: 28419674
[TBL] [Abstract][Full Text] [Related]
33. Treatments for psoriasis and the risk of malignancy.
Patel RV; Clark LN; Lebwohl M; Weinberg JM
J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
35. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma.
Wei Q; Lee JE; Gershenwald JE; Ross MI; Mansfield PF; Strom SS; Wang LE; Guo Z; Qiao Y; Amos CI; Spitz MR; Duvic M
J Natl Cancer Inst; 2003 Feb; 95(4):308-15. PubMed ID: 12591987
[TBL] [Abstract][Full Text] [Related]
36. Risk of cutaneous malignant melanoma in patients with celiac disease: a population-based study.
Lebwohl B; Eriksson H; Hansson J; Green PH; Ludvigsson JF
J Am Acad Dermatol; 2014 Aug; 71(2):245-8. PubMed ID: 24792481
[TBL] [Abstract][Full Text] [Related]
37. Association between dietary fat and skin cancer in an Australian population using case-control and cohort study designs.
Granger RH; Blizzard L; Fryer JL; Dwyer T
BMC Cancer; 2006 May; 6():141. PubMed ID: 16734890
[TBL] [Abstract][Full Text] [Related]
38. Body site of cutaneous malignant melanoma--a study on patients with hereditary and multiple sporadic tumours.
Gillgren P; Brattström G; Frisell J; Palmgren J; Ringborg U; Hansson J
Melanoma Res; 2003 Jun; 13(3):279-86. PubMed ID: 12777983
[TBL] [Abstract][Full Text] [Related]
39. Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women.
Pérez-Gómez B; Aragonés N; Gustavsson P; Lope V; López-Abente G; Pollán M
Br J Dermatol; 2008 Apr; 158(4):766-72. PubMed ID: 18241261
[TBL] [Abstract][Full Text] [Related]
40. A prospective cohort study on dietary acrylamide intake and the risk for cutaneous malignant melanoma.
Lipunova N; Schouten LJ; van den Brandt PA; Hogervorst JGF
Eur J Cancer Prev; 2017 Nov; 26(6):528-531. PubMed ID: 27128581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
